|Videos|March 30, 2021

Targeting PSMA in Advanced Prostate Cancer

Experts in genitourinary oncology discuss emerging research surrounding the clinical utility of phenotypic biomarkers, such as prostate-specific membrane antigen (PSMA), for use in the treatment of metastatic castration-resistant prostate cancer.


Latest CME